LA HB435 | 2023 | Regular Session
Status
Completed Legislative Action
Spectrum: Partisan Bill (Democrat 1-0)
Status: Passed on June 12 2023 - 100% progression
Action: 2023-06-12 - Effective date: 08/01/2023.
Text: Latest bill text (Chaptered) [PDF]
Spectrum: Partisan Bill (Democrat 1-0)
Status: Passed on June 12 2023 - 100% progression
Action: 2023-06-12 - Effective date: 08/01/2023.
Text: Latest bill text (Chaptered) [PDF]
Summary
Provides relative to medicaid coverage of chimeric antigen receptor T-cell therapy (EN SEE FISC NOTE GF EX See Note)
Title
Provides relative to medicaid coverage of chimeric antigen receptor T-cell therapy (EN SEE FISC NOTE GF EX See Note)
Sponsors
Roll Calls
2023-06-06 - House - House Vote on HB 435 CONCUR IN SENATE AMENDMENTS (#1034) (Y: 100 N: 0 NV: 0 Abs: 5) [PASS]
2023-06-04 - Senate - Senate Vote on HB 435 FINAL PASSAGE (#721) (Y: 37 N: 0 NV: 0 Abs: 2) [PASS]
2023-05-03 - House - House Vote on HB 435 FINAL PASSAGE (#208) (Y: 101 N: 1 NV: 0 Abs: 3) [PASS]
2023-06-04 - Senate - Senate Vote on HB 435 FINAL PASSAGE (#721) (Y: 37 N: 0 NV: 0 Abs: 2) [PASS]
2023-05-03 - House - House Vote on HB 435 FINAL PASSAGE (#208) (Y: 101 N: 1 NV: 0 Abs: 3) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2023-06-12 | House | Effective date: 08/01/2023. |
| 2023-06-12 | House | Signed by the Governor. Becomes Act No. 294. |
| 2023-06-09 | House | Sent to the Governor for executive approval. |
| 2023-06-08 | Senate | Signed by the President of the Senate. |
| 2023-06-07 | House | Enrolled and signed by the Speaker of the House. |
| 2023-06-06 | House | Read by title, roll called, yeas 100, nays 0, Senate amendments concurred in. |
| 2023-06-04 | House | Scheduled for concurrence on 06/06/2023. |
| 2023-06-04 | House | Received from the Senate with amendments. |
| 2023-06-04 | Senate | Rules suspended. Senate floor amendments read and adopted. Read by title, passed by a vote of 37 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled. |
| 2023-05-15 | Senate | Reported without Legislative Bureau amendments. Read by title and passed to third reading and final passage. |
| 2023-05-11 | Senate | Read by title and referred to the Legislative Bureau. |
| 2023-05-10 | Senate | Reported favorably. |
| 2023-05-04 | Senate | Read second time by title and referred to the Committee on Health and Welfare. |
| 2023-05-03 | Senate | Received in the Senate. Read first time by title and placed on the Calendar for a second reading. |
| 2023-05-03 | House | Read third time by title, roll called on final passage, yeas 100, nays 1. Finally passed, title adopted, ordered to the Senate. |
| 2023-04-26 | House | Scheduled for floor debate on 05/03/2023. |
| 2023-04-26 | House | Read by title, ordered engrossed, passed to 3rd reading. |
| 2023-04-25 | House | Reported favorably (12-0). |
| 2023-04-10 | House | Read by title, under the rules, referred to the Committee on Health and Welfare. |
| 2023-04-03 | House | First appeared in the Interim Calendar on 4/3/2023. |
| 2023-03-30 | House | Under the rules, provisionally referred to the Committee on Health and Welfare. |
| 2023-03-30 | House | Prefiled. |
